NasdaqGS:ICLRLife Sciences
How ICON’s AI-Focused Partnership with Advarra Could Reshape ICLR’s Clinical Trial Efficiency Narrative
In March 2026, ICON plc and Advarra announced a partnership to create a connected, “research-ready” site network that links ICON’s clinical trial solutions with Advarra’s widely used site technologies to reduce administrative friction, speed up study startup, and expand trial access globally.
This collaboration gives ICON access to Advarra’s data and AI-driven operational intelligence, potentially refining protocol design, forecasting, and site selection by aligning studies more closely with...